Skip to main content
. 2006 Mar 9;173(12):1335–1341. doi: 10.1164/rccm.200603-341OC

TABLE 2.

CLINICAL CHARACTERISTICS BY IRAK-1 HAPLOTYPE

IRAK-1 Haplotype Variant Heterozygous Wild Type
N (%) 21 (14) 12 (8) 122 (78)
Age, yr (mean ± SD) 53 ± 14.7 45 ± 20 52.5 ± 16.5
Male, % 80.0 0.0 60.0
Cancer, % 19.0 0.0 22.4
End-stage liver failure, % 14.3 18.0 10.4
Chronic obstructive pulmonary disease, % 9.5 9.0 8.0
Alcohol abuse, % 19.0 18.0 15.2
Diabetes, % 19.0 27.0 16.0
Immunosuppression, % 23.8 27.0 23.2
Congestive heart failure, % 4.8 0.0 8.8
HIV, % 0.0 0.0 0.0